Welcome to our dedicated page for Tactile Systems SEC filings (Ticker: TCMD), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Tactile Systems Technology, Inc. filings document a Nasdaq-listed medical technology issuer with common stock registered under the ticker TCMD. Recent Form 8-K reports disclose quarterly and annual operating results, financial condition updates, acquisition-related Regulation FD materials, FDA and product-related business highlights, share repurchase authorization activity and other corporate events.
The company's proxy and governance filings cover board composition, director elections, committee assignments, executive compensation, shareholder voting matters and amendments to its certificate of incorporation. Its SEC disclosures also identify Delaware incorporation, Nasdaq listing status, capital actions and governance provisions relevant to its public-company structure.
Tactile Systems Technology, Inc. held its 2026 annual meeting on May 6, 2026, where stockholders elected all nine director nominees for terms running until the 2027 annual meeting. Each nominee received over 15.3 million votes in favor, with relatively few votes withheld and 3,011,527 broker non-votes for each.
Stockholders also ratified the selection of Grant Thornton LLP as independent registered public accounting firm for the year ending December 31, 2026, with 18,499,882 votes for and 126,747 against. In an advisory vote, stockholders approved executive compensation, and they approved an amendment to the Amended and Restated Certificate of Incorporation so directors may be removed in a manner consistent with Delaware law.
Tactile Systems Technology, Inc. reported first‑quarter 2026 revenue of $75.3 million, up 23% from $61.3 million a year earlier, driven by growth in both lymphedema and airway clearance products. Gross margin improved to 77% from 74%, but the company posted a net loss of $1.8 million, narrower than the $3.0 million loss in the prior‑year quarter.
Lymphedema products generated $62.2 million, or 83% of revenue, while airway clearance products contributed $13.0 million, or 17%. Cash was $75.0 million with no borrowings on a $40.0 million revolving credit facility, providing liquidity alongside ongoing share repurchases of $1.1 million in the quarter.
During the quarter, Tactile Systems closed the LymphaTech acquisition for $7.2 million in cash plus contingent consideration initially valued at $4.9 million, adding 3D measurement technology and $8.5 million of goodwill. The company also recorded a $1.0 million accrual tied to an agreement in principle to settle previously disclosed False Claims Act lawsuits.
Tactile Systems Technology, Inc. reported a strong first quarter of 2026, with total revenue rising 23% to $75.3 million from $61.3 million a year earlier. Growth was broad-based, as lymphedema product revenue increased to $62.2 million and airway clearance revenue rose to $13.0 million, each maintaining 83% and 17% of total sales.
Gross profit grew 27% to $57.6 million and gross margin improved to 76.5%. Operating loss narrowed to $1.5 million and net loss improved to $1.8 million, or $0.08 per diluted share. Adjusted EBITDA swung to a positive $3.7 million from a small loss, helped by higher revenue and operating leverage.
As of March 31, 2026, the company held $75.0 million in cash with no borrowings and repurchased $1.1 million of stock. Management raised its 2026 revenue outlook to $360–$368 million, implying 9%–12% growth over 2025, while maintaining adjusted EBITDA guidance of $49–$51 million. The quarter also reflected integration of the LymphaTech acquisition and ongoing investment in R&D and commercialization.
The Vanguard Group filed Amendment No. 7 to a Schedule 13G/A reporting zero beneficial ownership of Tactile Systems Technology Inc common stock. The filing states that, following an internal realignment on January 12, 2026 and in reliance on SEC Release No. 34-39538, certain Vanguard subsidiaries will report holdings separately and The Vanguard Group no longer is deemed to beneficially own securities held by those subsidiaries. The filing lists 0 shares and 0% beneficial ownership and is signed by Ashley Grim, Head of Global Fund Administration, dated 03/27/2026.
Tactile Systems Technology, Inc. is asking stockholders to vote at its May 6, 2026 annual meeting on four main items: electing nine directors, ratifying Grant Thornton LLP as auditor, approving 2025 executive pay on an advisory basis, and amending its charter so directors can be removed with or without cause by a majority vote, consistent with Delaware law.
The board notes that 8 of 9 nominees are independent and that the chair and CEO roles are separated. Executive pay is framed as pay-for-performance: in 2025 the company generated $329.5 million in revenue and $44.8 million in Adjusted EBITDA, resulting in management incentive plan payouts at 115% of target and strong PSU vesting outcomes tied to revenue growth and margin.
Pearson Andrea reported acquisition or exercise transactions in this Form 4 filing.
Tactile Systems Technology Inc. director Andrea Pearson received an equity award of 852 shares of Common Stock. These shares are in the form of restricted stock units granted at no cash cost and will vest in full on the date of the company's 2026 annual meeting of stockholders. Following this grant, Pearson holds 852 shares directly, indicating this filing reflects a routine compensation-related award rather than an open-market purchase or sale.
Tactile Systems Technology Inc. director Andrea Pearson filed an initial statement of beneficial ownership as required for insiders. The Form 3 data identifies her role as a director and shows no reported insider transactions or derivative holdings associated with this filing.
Tactile Systems Technology, Inc. is soliciting proxies for its 2026 Annual Meeting of Stockholders to be held on May 6, 2026, with a record date of March 12, 2026.
The meeting asks holders to elect nine directors, ratify Grant Thornton LLP as auditor for the year ending December 31, 2026, approve an advisory "say-on-pay" for 2025 executive compensation, and approve an amendment to the Company’s Amended and Restated Certificate of Incorporation to permit director removal in a manner consistent with Delaware law. Proxy voting methods and meeting logistics are provided.
Tactile Systems Technology, Inc. appointed Andrea A. Pearson to its board of directors, effective March 9, 2026, and set the board size at nine members. She will serve on the Compliance and Reimbursement Committee and the Nominating and Corporate Governance Committee.
For her board service, Ms. Pearson will receive restricted stock units valued at a pro rata portion of $155,000, granted March 9, 2026, vesting on the date of the Company’s 2026 annual stockholders’ meeting if she remains a director. She will also receive annual cash retainers of $50,000 for board service and $5,000 each for her roles on the two committees, all prorated for her first year.